Louisiana Attorney General’s Generic Flonase Lawsuit Remanded To State Court

(February 8, 2016, 12:28 PM EST) -- BATON ROUGE, La. — A Louisiana federal judge on Feb. 4 remanded the state attorney general’s action involving generic Flonase to state court, finding that that state’s claims are based on violations of Louisiana state laws and not on federal regulation of the brand-name drug as claimed by defendant GlaxoSmithKline PLC (State of Louisiana v. SmithKline Beecham Corporation, No. 15-55, M.D. La.).

(Louisiana opinion available. Document #28-160218-006Z.)

In 2014, Louisiana sued SmithKline Beecham Corp. (now GlaxoSmithKline PLC, or GSK) in the East Baton Rouge Parish District...
To view the full article, register now.